Valens Semiconductor (VLN) Q4 2024 earnings summary

Executive summary

• 2024 revenue was $57.9M, with Q4 revenue of $16.7M exceeding guidance, and a diversified customer base across ProAV, automotive, industrial, and medical sectors.

• Over 40M chipsets sold, 125 patents, and ~$0.5B cumulative R&D investment highlight technological leadership.

• 2024 was challenging due to inventory digestion and weak customer markets, but management expects a turnaround in 2025, supported by new design wins, an acquisition, and product launches.

• Three automotive ADAS platform design wins, the acquisition of Acroname, and the launch of the VS6320 chipset were key milestones.

• A five-year plan aims to quadruple revenues by 2029, targeting high-growth markets like industrial machine vision and medical endoscopy.

Financial highlights

• Q4 2024 revenue was $16.7M, exceeding guidance; full-year 2024 revenue was $57.9M, down from $84.2M in 2023.

• Q4 gross margin was 60.4% GAAP (64.5% non-GAAP); full-year gross margin was 59.2% GAAP (62.9% non-GAAP).

• Q4 adjusted EBITDA loss was $3.7M; full-year adjusted EBITDA loss was $21.1M.

• Q4 GAAP net loss was $7.3M; full-year GAAP net loss was $36.6M; loss per share for 2024 was $0.35.

• Ended 2024 with $131M in cash and no debt; working capital was $133.6M.

Outlook and guidance

• 2025 revenue expected between $71M-$76M, representing 23%-31% year-over-year growth.

• Q1 2025 revenue guidance is $16.3M-$16.6M; gross margin expected at 60.8%-61.3%; adjusted EBITDA loss of $4.5M-$4.2M.

• Five-year plan targets $220M-$300M revenue by 2029, with gross margin of 50%-60% and EBITDA margin of 15%-20%.

• Growth drivers include new product adoption (VS6320, VA7000), automotive design wins, and potential acquisitions.